Wednesday, July 9, 2014

10 Best Net Payout Yield Stocks To Invest In 2015

Pennsylvania Real Estate Investment Trust� (NYSE: PEI  ) �reported first-quarter results yesterday that were below consensus expectations on the top line but came in ahead on the bottom line, causing the company to�raise guidance�for the full year.

Pennsylvania REIT reported revenues for the three months ended March 31 of $106 million, up 3% from the same period last year when it recorded revenues just under $103 million.�With funds from operations (FFO) of $24.2 million recorded in the first quarter, down $0.8 million from last year, the REIT now expects full-year FFO to be in the range of $2.00 to $2.08 per share, some 2% ahead of the $1.95 to $2.05 per share it previously pegged FFO to come in at.

Pennsylvania REIT CEO�Joseph F. Coradino said, "We are off to a strong start in 2013. During the first quarter, we delivered strong operating results, increased the dividend on our common shares, refinanced property-level debt at lower interest rates, disposed of non-core assets improving the quality of our portfolio, and last week refinanced our credit facility on highly favorable terms."

10 Best Net Payout Yield Stocks To Invest In 2015: Recon Technology Ltd.(RCON)

Recon Technology, Ltd. provides hardware, software, and on-site services to companies in the petroleum mining and extraction industry in the People?s Republic of China. The company offers equipment, tools, and other hardware related to oilfield production and management; and develop and sell industrial automation control and information solutions. Its oil and gas production and transportation equipment comprise heating furnaces, burners, and separators. Recon Technology, Ltd.?s oil and gas development tools and equipment include packers of fracturing, production packers, and water injection packers; and oil and gas production increasing techniques consist of fissure shaper technique to increase perforation depth, sand prevention in oil and water well technique, water locating and plugging technique, fracture acidizing technique, and electronic broken-down service. Its automation systems and services comprise pumping unit controllers that monitors the pumping units and co llects data for load, pressure, voltage, startup, and shutdown control; RTU for monitoring natural gas wells and collecting gas well pressure data; wireless dynamometer and wireless pressure gauge; electric multi-way valve for oilfield metering station flow control; and natural gas flow computer system to measure the flow. The company?s automation systems and services also consist of Recon SCADA oilfield monitor and data acquisition system for supervision and data collection; EPC service of pipeline SCADA system for pipeline monitoring and data acquisition; EPC service of oil and gas wells SCADA system for monitoring and data acquisition of oil, and natural gas wells; EPC service of oilfield video surveillance and control system to control the oil and gas wellhead area and measure station area; and technique service for digital oilfield transformation. Recon Technology, Ltd. was incorporated in 2007 and is headquartered in Beijing, the People?s Republic of China.

Advisors' Opinion:
  • [By James E. Brumley]

    Anybody who was lucky enough to get into a Recon Technology, Ltd. (NASDAQ:RCON) position before October 7th, then congratulations - you're up big-time. Now get out. Instead, a better use of that capital is Mitek Systems, Inc. (NASDAQ:MITK). While RCON is overbought and ripe for a pullback, MITK is itching to stage a breakout.

10 Best Net Payout Yield Stocks To Invest In 2015: Philip Morris International Inc(PM)

Philip Morris International Inc., through its subsidiaries, engages in the manufacture and sale of cigarettes and other tobacco products in markets outside of the United States. Its international product brand line comprises Marlboro, Merit, Parliament, Virginia Slims, L&M, Chesterfield, Bond Street, Lark, Muratti, Next, Philip Morris, and Red & White. The company also offers its products under the A Mild, Dji Sam Soe, and A Hijau in Indonesia; Diana in Italy; Optima and Apollo-Soyuz in the Russian Federation; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; Best and Classic in Serbia; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia. It operates primarily in the European Union, Eastern Europe, the Middle East, Africa, Asia, Canada, and Latin America. The company is based in New York, New York.

Advisors' Opinion:
  • [By Jacob Roche]

    A recent report from research group KPMG, and commissioned by Philip Morris (NYSE: PM  ) , revealed that while total consumption of cigarettes in Europe has fallen in recent years, the illegal contraband and counterfeit trade has grown from 8.3% of total consumption to 11.1%. The report suggests that the high profitability and low risk of penalties attracts organized crime, which can use the trade as a cash cow to fund far more objectionable activities. An ad from British American Tobacco (NYSEMKT: BTI  ) goes as far as to suggest that the trade could even be indirectly funding terrorism.

  • [By abirk]

    Philip Morris International (PM) is reaching new heights in 2013. With its products being sold in 180 countries it is the proud owner of about 15 cigarette brands- Marlboro, Merit, Parliament, Virginia Slims, L&M, and Chesterfield being some of them. FY2013 looks bright for this tobacco giant. Reasons Why 2013 Is Looking Bright

  • [By Rich Smith]

    The commonly accepted wisdom in the cigarette industry goes something like this: Smoking is in decline in the United States. Therefore, if you want to make money on tobacco, you must look abroad. You must buy Philip Morris International (NYSE: PM  ) stock.

  • [By Selena Maranjian]

    Why Altria?
    The company is what's left after international operations were spun off in the form of Philip Morris International (NYSE: PM  ) in 2008. While Philip Morris is favored by many because of lower tobacco taxes and regulations in many parts of the world, as well as the fact that many economies are growing more rapidly than ours, Altria still manages the very valuable Marlboro brand domestically, where it recently held a commanding 43% market share.

Top Stocks To Own Right Now: American Equity Investment Life Holding Company (AEL)

American Equity Investment Life Holding Company, through its subsidiaries, operates in the insurance business in 50 states and the District of Columbia. The company underwrites fixed annuities, including fixed index annuities and fixed rate annuities, as well as single premium immediate annuities. It also offers life insurance products comprising traditional ordinary and term, universal life, and other interest-sensitive life insurance products. The company markets its products through a brokerage distribution network of approximately 60 national marketing organizations and approximately 24,000 independent agents. American Equity Investment Life Holding Company was founded in 1995 and is based in West Des Moines, Iowa.

Advisors' Opinion:
  • [By Louis Navellier]

    American Equity Life (AEL) specializes in fixed-rate and index annuities, and business has been booming as cautious investors and savers look for places to put their money. The company has posted four consecutive positive earnings surprises, causing analysts to raise their estimates for 2014 in the past few months. The shares are still cheap when viewed thought the lenses of the P/E ratio, but more importantly, AEL has the type of solid fundamentals and investor demand that signify a potential winning stock. Shares of American Equity were upgraded to an ����grade back in August, and AEL remains a ��trong buy.��/p>

10 Best Net Payout Yield Stocks To Invest In 2015: Hillenbrand Industries Inc. (HRC)

Hill-Rom Holdings, Inc. manufactures and provides medical technologies and related services for the health care industry worldwide. It offers patient support system, safe mobility and handling solutions, medical equipment rental services, surgical products, and information technology solutions, as well as non-invasive therapeutic products for acute and chronic medical conditions. The company rents and sells patient support systems, which include various bed systems, and integrated and non-integrated therapeutic bed surfaces for use in high, mid, and low acuity settings; and non-invasive therapeutic products and surfaces for the prevention and treatment of various acute and chronic medical conditions, including pulmonary, wound, and bariatric conditions. It also provides rentals and health care provider asset management services for moveable medical equipment, such as ventilators, defibrillators, intravenous pumps, and patient monitoring equipment; mobility solutions, inclu ding lifts and other devices used to move patients; architectural products comprising headwalls and power columns; and health care furniture solutions. In addition, the company develops and markets various communications technologies and software solutions primarily to improve patient safety at the point of care; and surgical products, including a range of positioning devices for use in shoulder, hip, spinal, and lithotomic surgeries, as well as platform-neutral positioning accessories for operating room tables. It sells its products primarily to acute and extended care health care facilities through direct sales force and distributors. The company was formerly known as Hillenbrand Industries, Inc. and changed its name to Hill-Rom Holdings, Inc. in March 2008. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Batesville, Indiana.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Hill-Rom Holdings (NYSE: HRC  ) , whose recent revenue and earnings are plotted below.

10 Best Net Payout Yield Stocks To Invest In 2015: Covidien PLC (COV)

Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity. Advisors' Opinion:
  • [By Keith Speights]

    Covidien (NYSE: COV  ) battles against 3M for market share in the medical devices and supplies arena. Net sales for Covidien's medical devices unit in 2012 were $8.1 billion. The company's medical supplies segment contributed another $1.7 billion in sales. The total of the two business segments nearly doubles that of 3M Health Care.

  • [By Dan Carroll]

    Finally, Covidien (NYSE: COV  ) has also entered the renal denervation race, although this company looks to be behind St. Jude and Medtronic as the leaders. Covidien purchased small-time renal denervation player Maya Medical last year for up to $170 million including milestone payouts, and it also received European approval for its OneShot renal denervation system last year. However, Covidien only launched the OneShot commercially in January, putting it back with Boston Scientific in racing to catch up with St. Jude and Medtronic's advance.

10 Best Net Payout Yield Stocks To Invest In 2015: BreitBurn Energy Partners L.P.(BBEP)

BreitBurn Energy Partners L.P. engages in the acquisition, exploitation, and development of oil and gas properties in the United States. The company?s properties include natural gas, oil, and midstream assets comprising fields in the Antrim Shale in Michigan, and the New Albany Shale in Indiana and Kentucky; and fields in the Evanston and Green River basins in southwestern Wyoming, the Wind river and Big Horn basins in central Wyoming, the Powder River basin in eastern Wyoming, the Los Angeles basin in California, and fields in Florida?s Sunniland Trend. As of December 31, 2011, its total estimated proved reserves were 151.1 million barrels of oil equivalent. BreitBurn GP, LLC serves as the general partner to the company. BreitBurn Energy Partners L.P. was founded in 2006 and is headquartered in Los Angeles, California.

Advisors' Opinion:
  • [By Aimee Duffy]

    Let's start with MLPs like Linn Energy (NASDAQ: LINE  ) or BreitBurn Energy Partners (NASDAQ: BBEP  ) . These are oil and gas exploration and production partnerships, and though this type of MLP is extremely exposed to commodity risk, commodity prices are tied to inflation, which in turn poses little threat to the partnerships.

10 Best Net Payout Yield Stocks To Invest In 2015: Insys Therapeutics Inc (INSY)

Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company�� pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company�� product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).

Subsys

The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.

Dronabinol Product Family

The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.

Cancer Therapeutics

In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.

The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Equities Trading DOWN
    Shares of INSYS Therapeutics (NASDAQ: INSY) were down 15.94 percent to $38.00 after the company received subpoena from Office of Inspector General.

  • [By Jake L'Ecuyer]

    INSYS Therapeutics (NASDAQ: INSY) was also down, falling 15.14 percent to $27.73 after news broke that a doctor had fraudulently prescribed its drug Subsys.

10 Best Net Payout Yield Stocks To Invest In 2015: Viad Corp(VVI)

Viad Corp, together with its subsidiaries, operates in exhibition and events, and travel and recreation industries primarily in North America, the United Kingdom, Germany, and the United Arab Emirates. The company?s Marketing & Events Group segment designs, plans, and produces face-to-face events for show organizers, corporate brand marketers, and retail shopping centers. It offers general event management, planning and consultation, concept design, exhibition layout and design, graphics and design, show traffic analysis, carpeting and flooring, decorating products and accessories, custom graphics, overhead rigging, and cleaning services, as well as temporary electrical, lighting, and plumbing services. This segment also provides custom exhibit design and construction; portable and modular exhibits and design; integrated marketing, including pre- and post-event communications and customer relationship management; multimedia services; event surveys; return on investment an alysis; attendee and exhibit booth traffic analysis; staff training; online management tools; logistics and freight-forwarding, storage, and refurbishment of exhibits; booth furnishings, carpeting, and signage; in-house installation and dismantling; and various other show services. In addition, the segment offers various entertaining attractions and brand-based experiences, sponsored events, mobile marketing and other branded entertainment, and face-to-face marketing solutions for clients and venues, including movie studios, leading consumer brand marketers, shopping malls, museums, and casinos. Its Travel & Recreation Group segment provides tourism products, including attractions, transportation services, inbound package tour operations, hotel operations, and corporate and event management; operates five lodges, three motor inns, and one resort hotel; and engages in food and beverages, and retail and concession businesses. Viad Corp was founded in 1914 and is headquartered in Phoenix, Arizona.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Viad Corp (NYSE: VVI  ) , whose recent revenue and earnings are plotted below.

10 Best Net Payout Yield Stocks To Invest In 2015: Genesco Inc. (GCO)

Genesco Inc. engages in the retail and wholesale of footwear, apparel, and accessories. The company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment operates the Journeys, Journeys Kidz, Shi by Journeys, and Underground by Journeys retail stores that provide footwear and accessories for men, women, and younger children. It also sells footwear and accessories through direct-to-consumer catalog and e-commerce operations. The Schuh Group segment operates Schuh retail footwear stores, which offer casual and athletic footwear for 15 to 30 year old men and women, as well as engages in the e-commerce operations. The Lids Sports Group segment operates headwear and accessory stores under the Lids, Hat World, and Hat Shack banners; sports-oriented fan shops that offer licensed merchandise, such as apparel, hats and accessories, sports decor, and novelty products under the Lids Locker R oom, Sports Fan-Attic, and Sports Avenue banners; and as a Lids Team Sports athletic team dealer, as well as in e-commerce operations. The Johnston & Murphy Group segment is involved in Johnston and Murphy retail, catalog and e-commerce, and wholesale distribution operations. Its stores provide footwear, luggage, and accessories for business and professional customers. The Licensed Brands segment markets casual and dress footwear under the Dockers brand for men aged 30 to 55. As of May 31, 2013, the company operated 2,455 retail stores in the United States, Canada, the United Kingdom, and the Republic of Ireland. The company also sells its products through journeys.com, journeyskidz.com, shibyjourneys.com, undergroundbyjourneys.com, schuh.co.uk, and johnstonmurphy.com. Genesco Inc. was founded in 1924 and is headquartered in Nashville, Tennessee.

Advisors' Opinion:
  • [By Eric Volkman]

    Genesco (NYSE: GCO  ) results for the company's fiscal Q1 2014 have been released. For the quarter, net sales came in at $591 million, a drop of 1.5% from the $600 million in the same period the previous year. Net profit also saw a slip, to $18.4 million ($0.77 per diluted share) from Q1 2013's figure of $20.6 million ($0.85). On an adjusted basis, those numbers were $22.2 million ($0.94 per diluted share) and $23.8 ($0.98), respectively.

  • [By Reuters]

    Steven Senne/AP BOSTON -- Companies that help Target process payments could face millions of dollars in fines and costs resulting from the unprecedented data breach that struck the retailer during the holiday shopping season. Investigators are still sorting through just how thieves compromised about 40 million payment cards and the information of about 70 million Target (TGT) customers. But people who have reviewed past data breaches believe Target's partners could face consumer lawsuits and fines that payment networks such as Visa (V) and MasterCard (MA) often levy after cybersecurity incidents. Target's partners "have deep pockets and are intimately involved in certain aspects of how Target gets paid," said Jamie Pole, a cybersecurity consultant in Asheboro, N.C., who works for government agencies and the financial industry. Fines and settlement costs could reach into the millions of dollars for individual companies, he said, though much will depend on how the ultimate liability for the breach is determined. Boston attorney Cynthia Larose of Mintz Levin said Target would likely seek to add its partners as defendants to lawsuits already filed over the breach. "These class-action lawsuits start to bring everyone in at some point," she said. After its systems were penetrated by hackers in the mid-2000s, retailer TJX Cos. (TJX) agreed to pay up to $40.9 million to cover fraud costs in a settlement with Visa. Visa also issued penalties of $880,000 against Fifth Third Bancorp (FITB) of Ohio, which processed transactions for TJX. Asked about the business relationships and possible costs, Target spokeswoman Molly Snyder declined to comment, citing the ongoing investigation and pending suits. A Visa spokeswoman declined to comment. A MasterCard spokesman said the company couldn't discuss an ongoing investigation. Handling Target Transactions Several companies are involved in any purchase from a store such as Target. A bank issues the consumer's payment card

10 Best Net Payout Yield Stocks To Invest In 2015: Simon Property Group Inc.(SPG)

Simon Property Group, Inc. is a real estate investment trust. The firm engages in investment, ownership, and management of properties. It invests in the real estate markets across the globe. The firm?s portfolio includes regional malls, premium outlet centers, the mills, community / lifestyle centers, and international properties. Simon Property Group was founded in 1960 and is based in Indianapolis, Indiana.

Advisors' Opinion:
  • [By Wallace Witkowski]

    While the big banks and financial firms have already reported earnings, Greenhaus noted this week will see the largest number of financial sector firms reporting than any other week. More than 20 S&P 500 financial sector companies report including several insurers such as Dow component Travelers Cos. (TRV) , a number of real-estate investment trusts such as Simon Properties Group Inc. (SPG) , capital markets firms such as Franklin Resources Inc. (BEN) �and State Street Corp. (STT) , as well as exchange operator Nasdaq OMX Group Inc. (NDAQ) �

  • [By Dividend King]

    Simon Property Group Inc (SPG): Simon Property Group Inc. is currently trading very close to its 52-week high of $139.63. In fact, that's an all-time high reached by the stock recently. It distributes an annual dividend of $3.80, has a yield of 2.80% and a payout ratio of 101%. Sales and income during the last 12 months increased 8.80% and 67.30%, respectively. Furthermore, revenue for the last four years has increased at a compound annual growth rate of 3.29% while income has increased at a compound annual growth rate of 21.93% during the same time period.

  • [By Reuben Brewer]

    Simon Property Group (NYSE: SPG  ) recently announced plans to spin off its strip malls and smaller enclosed malls into a new company. That will allow the mall giant to focus on its higher-end enclosed malls and outlets. The move will be a good one for shareholders on multiple fronts, but such transactions don't always play out this well.

No comments:

Post a Comment